NewAmsterdam Pharma Co N.V. — Investor Relations & Filings
NewAmsterdam Pharma Co N.V. is a clinical-stage biopharmaceutical company focused on developing therapies for metabolic diseases where currently approved treatments have not been sufficiently successful or well-tolerated. The company's lead product candidate is obicetrapib, an oral, low-dose, once-daily CETP inhibitor. It is being investigated as a therapy to lower low-density lipoprotein cholesterol (LDL-C) as an adjunct to maximally tolerated statin therapy for high-risk cardiovascular disease patients. The company aims to address the unmet need for a potent, cost-effective, and convenient LDL-lowering treatment. In addition to its dyslipidemia program, the company also explores treatments for other metabolic disorders.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-06-03 | English | |
| 8-K - NewAmsterdam Pharma Co N.V. (0001936258) (Filer) | 2026-05-07 | English | |
| 10-Q - NewAmsterdam Pharma Co N.V. (0001936258) (Filer) | 2026-05-07 | English | |
| ARS - NewAmsterdam Pharma Co N.V. (0001936258) (Filer) | 2026-05-06 | English | |
| DEF 14A - NewAmsterdam Pharma Co N.V. (0001936258) (Filer) | 2026-05-06 | English | |
| 4 - NEWAMSTERDAM PHARMA CO N.V. (0001936258) (Filer) | 2026-03-03 | English |
Browse filings by year
5 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47948171 | 8-K | 2026-06-03 | English | ||
| 42822293 | 8-K - NewAmsterdam Pharma Co N.V. (0001936258) (Filer) | 2026-05-07 | English | ||
| 42821986 | 10-Q - NewAmsterdam Pharma Co N.V. (0001936258) (Filer) | 2026-05-07 | English | ||
| 41812240 | ARS - NewAmsterdam Pharma Co N.V. (0001936258) (Filer) | 2026-05-06 | English | ||
| 41812260 | DEF 14A - NewAmsterdam Pharma Co N.V. (0001936258) (Filer) | 2026-05-06 | English | ||
| 32900532 | 4 - NEWAMSTERDAM PHARMA CO N.V. (0001936258) (Filer) | 2026-03-03 | English | ||
| 32900535 | 8-K - NEWAMSTERDAM PHARMA CO N.V. (0001936258) (Filer) | 2026-03-02 | English | ||
| 32900533 | 4 - NEWAMSTERDAM PHARMA CO N.V. (0001936258) (Filer) | 2026-02-27 | English | ||
| 32900534 | 4 - NEWAMSTERDAM PHARMA CO N.V. (0001936258) (Filer) | 2026-02-24 | English | ||
| 32225365 | 10-K Filing | 2026-02-18 | English | ||
| 32225334 | 8-K Filing | 2026-02-18 | English | ||
| 32225241 | S-8 Filing | 2026-02-18 | English | ||
| 32225276 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 32225349 | SCHEDULE 13G Filing | 2026-02-05 | English | ||
| 32225298 | 4 Filing | 2026-01-29 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for NewAmsterdam Pharma Co N.V., but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Alpha Tau Medical Ltd.
Clinical-stage oncology firm developing alpha radiation the…
|
DRTS | US | Professional, scientific and te… |
|
Alteogen Inc.
Biopharmaceutical firm developing biologics with proprietar…
|
196170 | KR | Professional, scientific and te… |
|
ALTERITY THERAPEUTICS LIMITED
Clinical-stage developer of disease-modifying therapies for…
|
ATH | AU | Professional, scientific and te… |
|
AlzeCure Pharma
Develops therapies for severe diseases, focusing on Alzheim…
|
ALZCUR | SE | Professional, scientific and te… |
|
AMPLIA THERAPEUTICS LIMITED
Clinical-stage developer of FAK inhibitors for solid tumors…
|
ATX | AU | Professional, scientific and te… |
|
ANAPTYSBIO, INC
Clinical-stage biotech developing immunology therapeutics f…
|
ANAB | US | Professional, scientific and te… |
|
ANATARA LIFESCIENCES LTD
Develops non-antibiotic gastrointestinal health solutions f…
|
ANR | AU | Professional, scientific and te… |
|
AngioLab, Inc.
Develops angiogenesis inhibitors for pharmaceuticals and he…
|
251280 | KR | Professional, scientific and te… |
|
Anhui Wanbang Pharmaceutical Technology Co.,Ltd.
Pharmaceutical CRO specializing in clinical trials, BE stud…
|
301520 | CN | Professional, scientific and te… |
|
Anixa Biosciences Inc
A clinical-stage biotech developing therapies and vaccines …
|
ANIX | US | Professional, scientific and te… |
NewAmsterdam Pharma Co N.V. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31355/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31355 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31355 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31355 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31355}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for NewAmsterdam Pharma Co N.V. (id: 31355)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.